Georgi Mihaylov

2.2k total citations
22 papers, 205 citations indexed

About

Georgi Mihaylov is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Georgi Mihaylov has authored 22 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Georgi Mihaylov's work include Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Protein Degradation and Inhibitors (4 papers). Georgi Mihaylov is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Protein Degradation and Inhibitors (4 papers). Georgi Mihaylov collaborates with scholars based in Bulgaria, Czechia and Spain. Georgi Mihaylov's co-authors include Ivan Špıčka, Meletios Α. Dimopoulos, Antonio Palumbo, Philippe Moreau, Tamás Masszi, David S. Siegel, Péter Rajnics, Jesús F. San Miguel, Rubén Niesvizky and Heinz Ludwig and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Georgi Mihaylov

21 papers receiving 200 citations

Peers

Countries citing papers authored by Georgi Mihaylov

Since Specialization

Citations

This map shows the geographic impact of Georgi Mihaylov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgi Mihaylov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgi Mihaylov more than expected).

Fields of papers citing papers by Georgi Mihaylov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgi Mihaylov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgi Mihaylov. The network helps show where Georgi Mihaylov may publish in the future.

Co-authorship network of co-authors of Georgi Mihaylov

This figure shows the co-authorship network connecting the top 25 collaborators of Georgi Mihaylov. A scholar is included among the top collaborators of Georgi Mihaylov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgi Mihaylov. Georgi Mihaylov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib—A Real-Life Longitudinal Study 2023 ·Cancers ·Vera Stoeva, Georgi Mihaylov, (unknown), Guenka Petrova, Konstantin Tachkov	3
2	Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic ITP in routine clinical practice in central and Eastern Europe: an analysis of the PLATON study 2021 ·Hematology ·(unknown), (unknown), (unknown), (unknown), Katja Björklöf, (unknown), Georgi Mihaylov	3
3	PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia 2020 ·memo - Magazine of European Medical Oncology ·Georgi Mihaylov, (unknown), (unknown), (unknown), O Cerná, (unknown), Daniela Niepel, Katja Björklöf, Peter Černelč	3
4	Calorimetric markers for monitoring of multiple myeloma and Waldenström’s macroglobulinemia patients 2018 ·European Biophysics Journal ·Svetla Todinova, Sashka Krumova, (unknown), (unknown), (unknown), Georgi Mihaylov, (unknown), Stefka G. Taneva	10
5	Real-world multiple myeloma management practice patterns and outcomes in six Central and Eastern European countries 2018 ·Polskie Archiwum Medycyny Wewnętrznej ·Daniel Coriu, Dominik Dytfeld, Daniela Niepel, Ivan Špıčka, (unknown), Georgi Mihaylov, (unknown), Leah Fink, (unknown), Katja Björklöf	14
6	Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment 2017 ·Blood Cancer Journal ·Meletios Α. Dimopoulos, A. Keith Stewart, Tamás Masszi, Ivan Špıčka, Albert Oriol, Roman Hájek, Laura Rosiñol, David S. Siegel, Georgi Mihaylov, (unknown), Péter Rajnics, Aleksandr Suvorov, Rubén Niesvizky, Andrzej Jakubowiak, Jesús F. San Miguel, Heinz Ludwig, Sunhee Ro, Sanjay Aggarwal, Philippe Moreau, Antonio Palumbo	44
7	Effect of autologous stem-cells transplantation of patients with multiple myeloma on the calorimetric markers of the serum proteome. Correlation with the immunological markers 2017 ·Thermochimica Acta ·(unknown), Svetla Todinova, (unknown), (unknown), (unknown), Georgi Mihaylov, (unknown), Sashka Krumova, Stefka G. Taneva	9
8	Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study 2017 ·British Journal of Haematology ·Meletios Α. Dimopoulos, A. Keith Stewart, Tamás Masszi, Ivan Špıčka, Albert Oriol, Roman Hájek, Laura Rosiñol, David S. Siegel, Georgi Mihaylov, Vesselina Goranova‐Marinova, Péter Rajnics, Aleksandr Suvorov, Rubén Niesvizky, Andrzej Jakubowiak, Jesús F. San Miguel, Heinz Ludwig, Antonio Palumbo, Mihaela Obreja, Sanjay Aggarwal, Philippe Moreau	45
9	Results of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemotherapy 2016 ·Wiener klinische Wochenschrift ·Radosław Mądry, (unknown), Ferdinand Haslbauer, (unknown), (unknown), (unknown), Tibor Csőszi, Georgi Mihaylov, Daniela Niepel, Christine Jaeger, (unknown), Alina Macovei, (unknown)	9
10	Extranodal marginal zone B-cell lymphoma arising in chronic myeloid leukaemia successfully treated with tyrosine kinase inhibitor: a case report. 2016 ·PubMed ·Georgi Mihaylov, (unknown), Vera Stoeva, Tihomir Dikov	4
11	Serum Albumin and Peripheral Blood Neutrophils at Diagnosis May Provide Additional Prognostic Information in Primary Nodal Diffuse Large-B-Cell Lymphoma Patients Treated with R-CHOP 2016 ·Blood ·(unknown), (unknown), Georgi Mihaylov, (unknown), (unknown)	1
12	Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study 2016 ·Blood ·Andrew Davies, Biljana Mihaljević, Santiago Mercadal, Georgi Mihaylov, Sirpa Leppä, (unknown), (unknown), (unknown), Mark Dixon, Martin Barrett, David MacDonald	1
13	Carfilzomib, lenalidomide, and dexamethasone (KRd) vs lenalidomide and dexamethasone (Rd) in patients with relapsed multiple myeloma (RMM) and early progression during prior therapy: Secondary analysis from the phase 3 study ASPIRE (NCT01080391). 2016 ·Journal of Clinical Oncology ·Heinz Ludwig, Meletios Α. Dimopoulos, Tamás Masszi, Ivan Špıčka, Albert Oriol Rocafiguera, Roman Hájek, Laura Rosiñol, David S. Siegel, Georgi Mihaylov, Vesselina Goranova‐Marinova, Péter Rajnics, Aleksandr Suvorov, Rubén Niesvizky, Andrzej Jakubowiak, Jesús F. San Miguel, Mihaela Obreja, Sanjay Aggarwal, Philippe Moreau, Antonio Palumbo	1
14	A clinical case of Trichophyton menthagrophytes and Microsporum canis co-infection in a Siberian tiger (Panthera tigris altaicа) 2016 ·BULGARIAN JOURNAL OF VETERINARY MEDICINE ·Georgi Mihaylov, Ilia Tsachev, V. Petrov, (unknown), (unknown), (unknown), (unknown)	2
15	Effect of carfilzomib, lenalidomide, and dexamethasone (KRd) vs lenalidomide and dexamethasone (Rd) in patients with relapsed multiple myeloma (RMM) by line of therapy: Secondary analysis from an interim analysis of the phase III study ASPIRE (NCT01080391). 2015 ·Journal of Clinical Oncology ·Meletios Α. Dimopoulos, A. Keith Stewart, S. Vincent Rajkumar, Tamás Masszi, Albert Oriol, Roman Hájek, Laura Rosiñol, David S. Siegel, Georgi Mihaylov, Vesselina Goranova‐Marinova, Péter Rajnics, Aleksandr Suvorov, Rubén Niesvizky, Andrzej Jakubowiak, Jesús F. San Miguel, Heinz Ludwig, Naseem J. Zojwalla, Philippe Moreau, Antonio Palumbo	6
16	The Neutropenia Prophylaxis Evaluation Program in Patients Receiving Myelosuppressive Chemotherapy with Moderate or High Risk of Febrile Netropenia – an Interim Analysis of the Diepp Study 2012 ·Annals of Oncology ·Tibor Csőszi, (unknown), Grzegorz Mazur, Georgi Mihaylov, (unknown), Ervin Tóth	1
17	Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia 2009 ·Current Medical Research and Opinion ·Valentina Tzekova, Georgi Mihaylov, Ivo Elezović, Rossen Koytchev, (unknown)	21
18	A CASE OF ASPERGILLOSIS IN A BEARDED VULTURE (GYPAETOS BARBATUS) 2008 ·Georgi Mihaylov, V. Petrov, (unknown), (unknown), G. Simeonova	4
19	COMPARATIVE INVESTIGATION ON SEVERAL PROTOCOLS FOR TREATMENT OF DERMATOPHYTOSЕS IN PETS 2008 ·Georgi Mihaylov, V. Petrov, (unknown)	2
20	Original Contribution CLINICAL AND EPIDEMIOLOGICAL STUDIES ON EXPERIMENTAL E. COLI (EPEC-015:Н-) INFECTION IN RABBITS − TRANSMISSION TO PROGENY 2005 ·(unknown), V. Petrov, Georgi Mihaylov	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact